Anti-protein S antibodies following a varicella infection: Detection, characterization and influence on thrombin generation

Journal of Thrombosis and Haemostasis

Volumn 3, Issue 6, 2005, Pages 1243-1249

  Regnault, V ^a   Boehlen, F ^b   Ozsahin, H ^b   Wahl, D ^a   De Groot, P G ^c   Lecompte, T ^a   De Moerloose, Philippe ^a,d  

^a INSERM   (France)

^b UNIVERSITY HOSPITAL   (Switzerland)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Antiphospholipid antibodies; Protein S; Purpura fulminans; Surface plasmon resonance; Thrombography; Varicella

Indexed keywords

ACTIVATED PROTEIN C; EPITOPE; PROTEIN ANTIBODY; PROTEIN S ANTIBODY; THROMBOPLASTIN; UNCLASSIFIED DRUG; AUTOANTIBODY; PROTEIN S; THROMBIN;

AMINO TERMINAL SEQUENCE; ANTIBODY DETECTION; ARTICLE; CASE REPORT; ENZYME LINKED IMMUNOSORBENT ASSAY; HERPES ZOSTER; HUMAN; HYPERCOAGULABILITY; IN VITRO STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN S DEFICIENCY; SURFACE PLASMON RESONANCE; THROMBIN TIME; ANAPHYLACTOID PURPURA; BIOSYNTHESIS; BLOOD; CHICKENPOX; EPITOPE MAPPING; IMMUNOLOGY; THROMBOPHILIA; TIME; VIROLOGY;

AUTOANTIBODIES; CHICKENPOX; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; HUMANS; MALE; PROTEIN S; PROTEIN S DEFICIENCY; PURPURA, SCHOENLEIN-HENOCH; SURFACE PLASMON RESONANCE; THROMBIN; THROMBOPHILIA; TIME FACTORS;

EID: 24944451560     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2005.01270.x     Document Type: Article

References (34)

1. Josephson C, Nuss R, Jacobson L, Hacker M, Murphy J, Weinberg A, Manco-Johnson M. The varicella-autoantibody syndrome. Pediatr Res 2001; 50: 345-52.
2. Alsina Manrique de Lara L, Zambudio Serts S, Piza Oliveras A, Toll Costa T, Garcioa Garcia JJ, Luaces Cubells C. Postvaricella purpura fulminans. Ann Pediatr (Barc) 2004; 60: 585-8.
3. D'Angelo A, Della Valle P, Crippa L, Pattarini E, Grimaldi L, Vigano D'Angelo S. Autoimmune protein S deficiency in a boy with severe thromboembolic disease. N Engl J Med 1993; 328: 1753-7.
4. Levin M, Eley B, Louis J, Cohen H, Young L, Heyderman R. Post-infectious purpura fulminans caused by an autoantibody directed against protein S. J Pediatr 1995; 127: 355-63.
5. Manco-Johnson M, Nuss R, Key N, Moertel C, Jacobson L, Meech S, Weinberg A, Lefkowitz J. Lupus anticoagulant and protein S deficiency in children with postvaricella purpura fulminans or thrombosis. J Pediatr 1996; 128: 319-23.
6. Peyvandi F, Faioni E, Moroni GA, Rosti A, Leo L, Moi M. Autoimmune protein S deficiency and deep vein thrombosis after chickenpox. Thromb Haemost 1996; 75: 212-13.
7. Van Ommen CH, van Wijnen M, de Groot FG, van der Horst CM, Peters M. Postvaricella purpura fulminans caused by acquired protein S deficiency resulting from antiprotein S antibodies, search for the epitopes. J Pediatr Hematol/Oncol 2002; 24: 413-16.
8. Bergmann F, Hoyee PF, D'Angelo SV, Mazzola G, Oestereich C, Barthels M, D'Angelo A. Severe autoimmune protein S deficiency in a boy with idiopathic purpura fulminans. Br J Haematol 1995; 89: 610-14.
9. Al-Ismail S, Collins P, Najib R, James-Ellison M, O'Hagan M. Postinfection purpura fulminans in a patient heterozygous for prothrombin G20210A and acquired protein S resistance. Pediatr Hematol Oncol 1999; 16: 561-4.
10. Kurugol Z, Vardar F, Ozkinay F, Kavakli K, Cetinkaya B, Ozkinay C. Lupus anticoagulant and protein S deficiency in a child who developed disseminated intravascular coagulation in association with varicella. Turk J Pediatr 2001; 43: 139-42.
11. Campanelli A, Kaya G, Ozsahin A, La Scala G, Boehlen F, de Moerloose P, Saurat J-H. Purpura fulminans in a child as a complication of chickenpox infection. Dermatology 2004; 208: 262-4.
12. Van Wijnen M, Stam JG, Chang GT, Meijers JC, Reitsma PH, Bertina RM, Bouna BN. Characterization of mini-protein S, a recombinant variant of protein S that lacks the sex hormone binding globulin-like domain. Biochem J 1998; 330: 389-96.
13. Koppelman SJ, Hackeng TM, Sixma JJ, Bouna BN. Inhibition of the intrinsic factor X activating complex by protein S: evidence for a specific binding of protein S to factor VIII. Blood 1995; 86: 1062-71.
14. Regnault V, De Maistre E, Geschier C, Briquel ME, André E, Stoltz JF, Lecompte T. A new fast one-step immunopreparation for activated protein C. Thromb Haemost 1995; 73: 1365.
15. Vallar L, Regnault V, Latger-Cannard V, Lecompte T. Beta2-glycoprotein I binding to platelet microparticle membrane specifically reduces immunoreactivity of glycoproteins IIb/IIIa. Thromb Haemost 2001; 85: 314-19.
16. de Moerloose P, Reber G, Perrier A, Pernegger T, Bounameaux H. Prevalence of factor V Leiden and prothrombin G20210A mutations in unselected patients with venous thromboembolism. Br J Haematol 2000; 110: 125-9.
17. de Moerloose P, Bounameaux H, Perrier A, Reber G. Performances of the VIDAS D-dimer new assay for the exclusion of venous thromboembolism. Thromb Haemost 2001; 85: 185-6.
18. Reber G, Arvieux J, Comby E, Degenne D, de Moerloose P, Sanmarco M, Potron G. Multicenter evaluation of nine commercial kits for the quantitation of anticardiolipin antibodies. Thromb Haemost 1995; 73: 444-51.
19. Reber G, Schousboe I, Tincani A, Sanmarco M, Kveder T, de Moerloose P, Boffa MC, Arvieux J. Inter-laboratory variability of anti-β2-glycoprotein I measurement. A collaborative study. Thromb Haemost 2002; 88: 66-73.
20. Guermazi S, Regnault V, Gorgi Y, Ayed K, Lecompte T, Dellagi K. Further evidence for the presence of anti-protein S autoantibodies in patients with systemic lupus erythematosus. Blood Coagul Fibrinolysis 2000; 11: 491-8.
21. Johnsson B, Lofas S, Linqvist G. Immobilization of proteins to carboxymethyldextran modified gold surface for biospecific interaction analysis in surface plasmon resonance. Anal Biochem 1991; 198: 268-77.
22. Sternberg R, Persson B, Roos H, Urbaniczky C. Quantitative determination of surface concentration of protein with surface plasmon resonance by using radiolabeled proteins. J Colloid Interface Sci 1991; 143: 513-26.
23. Regnault V, Beguin S, Lecompte T. Calibrated automated thrombin generation in frozen-thawed platelet-rich plasma to detect hypercoagulability. Pathophysiol Haemost Thromb 2003; 33: 23-9.
24. Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smedt E, Wagenvoord R, Lecompte T, Beguin S. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003; 33: 4-15.
25. Regnault V, Hemker HC, Wahl D, Lecompte T. Phenotyping the haemostatic system by thrombinography - potential for estimation of thrombotic risk. Thromb Res 2004; 114: 539-45.
26. He X, Shen L, Villoutreix BO, Dahlbäck B. Amino acid residues in thrombin-sensitive region and first epidermal growth factor domain of vitamin K-dependent protein S determining specificity of the activated protein C cofactor function. J Biol Chem 1998; 273: 27449-58.
27. McDonald JF, Shah AM, Schwalbe RA, Kisiel W, Dahlbäck B, Nelsestuen GL. Comparison of naturally occurring vitamin K-dependent proteins: correlation of amino sequences and membrane binding properties suggests a membrane contact site. Biochemistry 1997; 36: 5120-7.
28. Dahlbäck B, Villoutreix BO. Molecular recognition in the protein C anticoagulant pathway. J Thromb Haemost 2003; 1: 1525-34.
29. Rezende SM, Simmonds RE, Lane DA. Coagulation, inflammation, and apoptosis: different roles for protein S and the protein S-C4b binding protein complex. Blood 2004; 103: 1192-201.
30. Viseux V, Darnige L, Carmi E, Chaby G, Poulain JF, Cevallos R, Lok C, Denoeux JP. Pulmonary embolism and transitory anti-β2GPI antibodies in an adult with chickenpox. Lupus 2000; 9: 558-60.
31. Male C, Lechner K, Eichinger S, Kyrle PA, Kapiotis S, Wank H, Kaider A, Pabinger I. Clinical significance and the course of lupus anticoagulants in children. J Pediatr 1999; 134: 199-205.
32. Oosting JD, Derksen RH, Bobbink IW, Hackeng TM, Bouma BN, de Groot PG. Antiphospholipid antibodies directed against a combination of phospholipid with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism? Blood 1993; 81: 2618-25.
33. Regnault V, Béguin S, Wahl D, De Maistre E, Hemker HC, Lecompte T. Thrombinography shows acquired resistance to activated protein C in patients with lupus anticoagulants. Thromb Haemost 2003; 89: 208-12.
34. Busuttil DP, Hay CR, Lewis MA, Wynn RF. Aggressive multiple modality therapy for varicella-associated purpura fulminans. Br J Haematol 2000; 110: 1012-13.